SCHEMBL30849748

SCHEMBL30849748

CCN1CC[C@H](C(F)F)[C@](C)(CO)C1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29207316 0.80
SCHEMBL27150039 0.80
SCHEMBL27150038 0.80
SCHEMBL29207318 0.80
SCHEMBL29207283 0.78 SMN1; SMN2 (0.34) SMN1; SMN2
SCHEMBL30782490 0.76
SCHEMBL30849860 0.76 SMN1; SMN2 (0.35) SMN1; SMN2
SCHEMBL30849855 0.75 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL29207293 0.72 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL29207317 0.72 SMN1; SMN2 (0.34) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118772151-A Compounds with anti-KRAS mutant tumor activity 泰励生物科技(上海)有限公司 2024-10-15 CN disclosed
WO-2024207892-A1 COMPOUNDS HAVING ACTIVITY AGAINST KRAS-MUTANT TUMORS 泰励生物科技(上海)有限公司 2024-10-10 WO disclosed
CN-117800975-A Compounds with anti-KRAS mutant tumor activity 泰励生物科技(上海)有限公司 2024-04-02 CN disclosed